# Advancing hepatology through innovation and integration: iLIVER's vision for 2026

**Authors:** Zu-Chao Du, Ke-Chun Wang, Ming-Da Wang, Lei Cai, Jian-Hong Zhong, Tian Yang

PMC · DOI: 10.1016/j.iliver.2026.100224 · ILIVER · 2026-02-06

## Full-text entities

- **Diseases:** Liver diseases (MESH:D008107), metabolic syndrome (MESH:D024821), cancer (MESH:D009369), cholangiocarcinoma (MESH:D018281), hepato-pancreato-biliary diseases (MESH:D001660), metabolic dysfunction-associated fatty liver disease (MESH:D005234), obesity (MESH:D009765), hepatitis (MESH:D056486), HCC (MESH:D006528)
- **Chemicals:** BioRender (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12969396/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12969396/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12969396/full.md

---
Source: https://tomesphere.com/paper/PMC12969396